Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in African-Americans

Oncotarget

Volumn 3, Issue 11, 2012, Pages 1428-1438

  Walsh, Kyle M ^a   Amos, Christopher I ^b   Wenzlaff, Angela S ^c   Gorlov, Ivan P ^b   Sison, Jennette D ^a   Wu, Xifeng ^b   Spitz, Margaret R ^d   Hansen, Helen M ^a   Lu, Emily Y ^b   Wei, Chongjuan ^b   Zhang, Huifeng ^b   Chen, Wei ^b   Lloyd, Stacy M ^b   Frazier, Marsha L ^b   Bracci, Paige M ^a   Seldin, Michael F ^e   Wrensch, Margaret R ^a   Schwartz, Ann G ^c   Wiencke, John K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

African Americans; Genetic association; Lung cancer; Nicotine dependence; Smoking

Indexed keywords

MESSENGER RNA; NICOTINIC RECEPTOR;

AFRICAN AMERICAN; AGE DISTRIBUTION; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHROMOSOME 15Q; CHROMOSOME 2Q; CIGARETTES SMOKED PER DAY; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; LUNG CANCER; MAJOR CLINICAL STUDY; NICOTINIC ACETYLCHOLINE RECEPTOR CHRNA1 GENE; NICOTINIC ACETYLCHOLINE RECEPTOR GENE; NUMBER OF PACK YEAR; PROMOTER REGION; RECEPTOR GENE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

EID: 84872788481     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.746     Document Type: Article

References (35)

1. Wang Y, Broderick P, Webb E, Wu X, Vijayakrishnan J, Matakidou A, Qureshi M, Dong Q, Gu X, Chen WV, Spitz MR, Eisen T, Amos CI and Houlston RS. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet. 2008; 40(12):1407-1409.
2. Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, Mirabello L, Jacobs K, Wheeler W, Yeager M, Bergen AW, Li Q, Consonni D, Pesatori AC, Wacholder S, Thun M, et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet. 2009; 85(5):679-691.
3. Broderick P, Wang Y, Vijayakrishnan J, Matakidou A, Spitz MR, Eisen T, Amos CI and Houlston RS. Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res. 2009; 69(16):6633-6641.
4. McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, Byrnes G, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet. 2008; 40(12):1404-1406.
5. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Chen C, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature. 2008; 452(7187):633-637.
6. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, Dong Q, Zhang Q, Gu X, Vijayakrishnan J, Sullivan K, Matakidou A, Wang Y, Mills G, Doheny K, Tsai YY, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet. 2008; 40(5):616-622.
7. Hsiung CA, Lan Q, Hong YC, Chen CJ, Hosgood HD, Chang IS, Chatterjee N, Brennan P, Wu C, Zheng W, Chang GC, Wu T, Park JY, Hsiao CF, Kim YH, Shen H, et al. The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet. 6(8).
8. Van Dyke AL, Cote ML, Wenzlaff AS, Abrams J, Land S, Iyer P and Schwartz AG. Chromosome 5p Region SNPs Are Associated with Risk of NSCLC among Women. J Cancer Epidemiol. 2009; 2009:242151.
9. Hansen HM, Xiao Y, Rice T, Bracci PM, Wrensch MR, Sison JD, Chang JS, Smirnov IV, Patoka J, Seldin MF, Quesenberry CP, Kelsey KT and Wiencke JK. Fine mapping of chromosome 15q25.1 lung cancer susceptibility in African-Americans. Hum Mol Genet. 19(18):3652-3661.
10. Amos CI, Gorlov IP, Dong Q, Wu X, Zhang H, Lu EY, Scheet P, Greisinger AJ, Mills GB and Spitz MR. Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control study. J Natl Cancer Inst. 102(15):1199-1205.
11. Siegel R, Ward E, Brawley O and Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 61(4):212-236.
12. Schwartz AG, Cote ML, Wenzlaff AS, Land S and Amos CI. Racial differences in the association between SNPs on 15q25.1, smoking behavior, and risk of non-small cell lung cancer. J Thorac Oncol. 2009; 4(10):1195-1201.
13. Schwartz AG, Wenzlaff AS, Bock CH, Ruterbusch JJ, Chen W, Cote ML, Artis AS, Van Dyke AL, Land SJ, Harris CC, Pine SR, Spitz MR, Amos CI, Levin AM and McKeigue PM. Admixture mapping of lung cancer in 1812 African- Americans. Carcinogenesis. 32(3):312-317.
14. Fagan P, Moolchan ET, Lawrence D, Fernander A and Ponder PK. Identifying health disparities across the tobacco continuum. Addiction. 2007; 102 Suppl 2:5-29.
15. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, Manolescu A, Thorleifsson G, Stefansson H, Ingason A, Stacey SN, Bergthorsson JT, Thorlacius S, Gudmundsson J, Jonsson T, Jakobsdottir M, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 2008; 452(7187):638-642.
16. Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau O, Swan GE, Goate AM, Rutter J, Bertelsen S, Fox L, Fugman D, et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet. 2007; 16(1):36-49.
17. Shiraishi K, Kohno T, Kunitoh H, Watanabe S, Goto K, Nishiwaki Y, Shimada Y, Hirose H, Saito I, Kuchiba A, Yamamoto S and Yokota J. Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese. Carcinogenesis. 2009; 30(1):65-70.
18. Liu Y, Liu P, Wen W, James MA, Wang Y, Bailey-Wilson JE, Amos CI, Pinney SM, Yang P, de Andrade M, Petersen GM, Wiest JS, Fain PR, Schwartz AG, Gazdar A, Gaba C, et al. Haplotype and cell proliferation analyses of candidate lung cancer susceptibility genes on chromosome 15q24-25.1. Cancer Res. 2009; 69(19):7844-7850.
19. Lindstrom JM. Nicotinic acetylcholine receptors of muscles and nerves: comparison of their structures, functional roles, and vulnerability to pathology. Ann N Y Acad Sci. 2003; 998:41-52.
20. Tapper AR, McKinney SL, Nashmi R, Schwarz J, Deshpande P, Labarca C, Whiteaker P, Marks MJ, Collins AC and Lester HA. Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science. 2004; 306(5698):1029-1032.
21. Saccone NL, Saccone SF, Hinrichs AL, Stitzel JA, Duan W, Pergadia ML, Agrawal A, Breslau N, Grucza RA, Hatsukami D, Johnson EO, Madden PA, Swan GE, Wang JC, Goate AM, Rice JP, et al. Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. Am J Med Genet B Neuropsychiatr Genet. 2009; 150B(4):453-466.
22. Cabral DN, Napoles-Springer AM, Miike R, McMillan A, Sison JD, Wrensch MR, Perez-Stable EJ and Wiencke JK. Population- and community-based recruitment of African Americans and Latinos: the San Francisco Bay Area Lung Cancer Study. Am J Epidemiol. 2003; 158(3):272-279.
23. Kosoy R, Nassir R, Tian C, White PA, Butler LM, Silva G, Kittles R, Alarcon-Riquelme ME, Gregersen PK, Belmont JW, De La Vega FM and Seldin MF. Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America. Hum Mutat. 2009; 30(1):69-78.
24. Nassir R, Kosoy R, Tian C, White PA, Butler LM, Silva G, Kittles R, Alarcon-Riquelme ME, Gregersen PK, Belmont JW, De La Vega FM and Seldin MF. An ancestry informative marker set for determining continental origin: validation and extension using human genome diversity panels. BMC Genet. 2009; 10:39.
25. Hansen HM, Wiemels JL, Wrensch M and Wiencke JK. DNA quantification of whole genome amplified samples for genotyping on a multiplexed bead array platform. Cancer Epidemiol Biomarkers Prev. 2007; 16(8):1686-1690.
26. The International HapMap Project. Nature. 2003; 426(6968):789-796.
27. Pritchard JK, Stephens M and Donnelly P. Inference of population structure using multilocus genotype data. Genetics. 2000; 155(2):945-959.
28. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ and Sham PC. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007; 81(3):559-575.
29. Higgins JP, Thompson SG, Deeks JJ and Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
30. Howie BN, Donnelly P and Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009; 5(6):e1000529.
31. A map of human genome variation from population-scale sequencing. Nature. 467(7319):1061-1073.
32. Howie B, Marchini J and Stephens M. Genotype Imputation with Thousands of Genomes. G3: Genes, Genomes, Genetics. 1(6):457-470.
33. Dimas AS, Deutsch S, Stranger BE, Montgomery SB, Borel C, Attar-Cohen H, Ingle C, Beazley C, Gutierrez Arcelus M, Sekowska M, Gagnebin M, Nisbett J, Deloukas P, Dermitzakis ET and Antonarakis SE. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science. 2009; 325(5945):1246-1250.
34. Yang TP, Beazley C, Montgomery SB, Dimas AS, Gutierrez-Arcelus M, Stranger BE, Deloukas P and Dermitzakis ET. Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies. Bioinformatics. 26(19):2474-2476.
35. Zhang G, Marshall AL, Thomas AL, Kernan KA, Su Y, LeBoeuf RC, Dong XR and Tchao BN. In vivo knockdown of nicotinic acetylcholine receptor alpha1 diminishes aortic atherosclerosis. Atherosclerosis. 215(1):34-42.